Lead İlişkili Triküspit Yetmezliği

Mond HG, Proclemer A. The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009--a World Society of Arrhythmia's project. Pacing Clin Electrophysiol 2011; 34: 1013-27. doi: 10.1111/j.1540-8159.2011.03150.x

Addetia K, Harb SC, Hahn RT, et al. Cardiac Implantable Electronic Device Lead-Induced Tricuspid Regurgitation. JACC Cardiovasc Imaging 2019; 12: 622-36. doi: 10.1016/j.jcmg.2018.09.028

Magnusson P, Wennstrom L, Kastberg R, et al. Placement Of Cardiac PacemaKEr Trial (POCKET) - rationale and design: a randomized controlled trial. Heart Int 2017; 12: e8-e11. doi: 10.5301/heartint.5000235

Trankle CR, Gertz ZM, Koneru JN, et al. Severe tricuspid regurgitation due to interactions with right ventricular permanent pacemaker or defibrillator leads. Pacing Clin Electrophysiol 2018; 41: 845-53. doi: 10.1111/pace.13369

Al-Bawardy R, Krishnaswamy A, Rajeswaran J, et al. Tricuspid regurgitation and implantable devices. Pacing Clin Electrophysiol 2015; 38: 259-66. doi: 10.1111/pace.12530

Arabi P, Ozer N, Ates AH, et al. Effects of pacemaker and implantable cardioverter defibrillator electrodes on tricuspid regurgitation and right sided heart functions. Cardiol J 2015; 22: 637-44. doi: 10.5603/CJ.a2015.0060

Seo Y, Ishizu T, Nakajima H, et al. Clinical utility of 3-dimensional echocardiography in the evaluation of tricuspid regurgitation caused by pacemaker leads. Circ J 2008; 72: 1465-70. doi: 10.1253/circj.cj-08-0227

Delling FN, Hassan ZK, Piatkowski G, et al. Tricuspid Regurgitation and Mortality in Patients With Transvenous Permanent Pacemaker Leads. Am J Cardiol 2016; 117: 988-92. doi: 10.1016/j.amjcard.2015.12.038

Lee RC, Friedman SE, Kono AT, et al. Tricuspid Regurgitation Following Implantation of Endocardial Leads: Incidence and Predictors. Pacing Clin Electrophysiol 2015; 38: 1267-74. doi: 10.1111/pace.12701

Klutstein M, Balkin J, Butnaru A, et al. Tricuspid incompetence following permanent pacemaker implantation. Pacing Clin Electrophysiol 2009; 32 Suppl 1: S135-7. doi: 10.1111/j.1540-8159.2008.02269.x

de Cock CC, Vinkers M, Van Campe LC, et al. Long-term outcome of patients with multiple (> or = 3) noninfected transvenous leads: a clinical and echocardiographic study. Pacing Clin Electrophysiol 2000; 23: 423-6. doi: 10.1111/j.1540-8159.2000.tb00821.x

Mediratta A, Addetia K, Yamat M, Moss JD, Nayak HM, Burke MC, et al. 3D echocardiographic location of implantable device leads and mechanism of associated tricuspid regurgitation. JACC Cardiovasc Imaging 2014; 7: 337-47. doi: 10.1016/j.jcmg.2013.11.007

Cheng Y, Gao H, Tang L, et al. Clinical utility of three-dimensional echocardiography in the evaluation of tricuspid regurgitation induced by implantable device leads. Echocardiography 2016; 33: 1689-96. doi: 10.1111/echo.13314

Heaven DJ, Henein MY, Sutton R. Pacemaker lead related tricuspid stenosis: a report of two cases. Heart 2000; 83: 351-2. doi: 10.1136/heart.83.3.351

Wilner BR, Coffey JO, Mitrani R, et al. Perforated tricuspid valve leaflet resulting from defibrillator leads: a review of the literature. J Card Surg 2014; 29: 470-2. doi: 10.1111/jocs.12352

Lin G, Nishimura RA, Connolly HM, et al. Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads. J Am Coll Cardiol 2005; 45: 1672-5. doi: 10.1016/j.jacc.2005.02.037

Rajappan K. Permanent pacemaker implantation technique: part II. Heart 2009; 95: 334-42. doi: 10.1136/hrt.2008.156372

Barclay JL, Cross SJ, Leslie SJ. Entanglement of passive fix ventricular lead in tricuspid valve. Pacing Clin Electrophysiol 2008; 31: 138. doi: 10.1111/j.1540-8159.2007.00941.x

Moreno R, Zamorano J, Ortega A, et al. Tricuspid valve chordae rupture following pacemaker electrode replacement. Int J Cardiol 2003; 87: 291-2. doi: 10.1016/s0167-5273(02)00313-3

Andreas M, Gremmel F, Habertheuer A, et al. Case report: Pacemaker lead perforation of a papillary muscle inducing severe tricuspid regurgitation. J Cardiothorac Surg 2015; 10: 39. doi: 10.1186/s13019-015-0244-7

Fanari Z, Hammami S, Hammami MB, et al. The effects of right ventricular apical pacing with transvenous pacemaker and implantable cardioverter defibrillator on mitral and tricuspid regurgitation. J Electrocardiol 2015; 48: 791-7. doi: 10.1016/j.jelectrocard.2015.07.002

Chang JD, Manning WJ, Ebrille E, et al. Tricuspid Valve Dysfunction Following Pacemaker or Cardioverter-Defibrillator Implantation. J Am Coll Cardiol 2017; 69: 2331-41. doi: 10.1016/j.jacc.2017.02.055

Vaturi M, Kusniec J, Shapira Y, et al. Right ventricular pacing increases tricuspid regurgitation grade regardless of the mechanical interference to the valve by the electrode. Eur J Echocardiogr 2010; 11: 550-3. doi: 10.1093/ejechocard/jeq018

Stokes K, Anderson J, McVenes R, et al. The encapsulation of polyurethane-insulated transvenous cardiac pacemaker leads. Cardiovasc Pathol 1995; 4: 163-71. doi: 10.1016/1054-8807(95)00023-x

Candinas R, Duru F, Schneider J, et al. Postmortem analysis of encapsulation around long-term ventricular endocardial pacing leads. Mayo Clin Proc 1999; 74: 120-5. doi: 10.4065/74.2.120

Rainer PP, Schmidt A, Anelli-Monti M, et al. A swinging pacemaker lead promoting endocarditis and severe tricuspid regurgitation. J Am Coll Cardiol 2012; 59: e45. doi: 10.1016/j.jacc.2011.10.908

Enia F, Lo Mauro R, Meschisi F, et al. Right-sided infective endocarditis with acquired tricuspid valve stenosis associated with transvenous pacemaker: a case report. Pacing Clin Electrophysiol 1991; 14: 1093-7. doi: 10.1111/j.1540-8159.1991.tb02839.x

Nisanci Y, Yilmaz E, Oncul A, et al. Predominant tricuspid stenosis secondary to bacterial endocarditis in a patient with permanent pacemaker and balloon dilatation of the stenosis. Pacing Clin Electrophysiol 1999; 22: 393-6. doi: 10.1111/j.1540-8159.1999.tb00460.x

Lancellotti P, Moura L, Pierard LA, et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr 2010; 11: 307-32. doi: 10.1093/ejechocard/jeq031

Tamai R, Hara T, Yamada H, et al. Massive tricuspid regurgitation due to pacemaker-lead puncture of the tricuspid valve: successful diagnosis by 3-dimensional echocardiography. J Med Ultrason (2001) 2014; 41: 69-71. doi: 10.1007/s10396-013-0459-y

Nucifora G, Badano LP, Allocca G, et al. Severe tricuspid regurgitation due to entrapment of the anterior leaflet of the valve by a permanent pacemaker lead: role of real time three-dimensional echocardiography. Echocardiography 2007; 24: 649-52. doi: 10.1111/j.1540-8175.2007.00443.x

Miglioranza MH, Becker D, Jimenez-Nacher JJ, Moya JL, et al. A new view of an unusual pacemaker complication: role of three-dimensional transthoracic echocardiography. Echocardiography 2013; 30: E164-6. doi: 10.1111/echo.12188

Anwar AM, Geleijnse ML, Soliman OI, et al. Assessment of normal tricuspid valve anatomy in adults by real-time three-dimensional echocardiography. Int J Cardiovasc Imaging 2007; 23: 717-24. doi: 10.1007/s10554-007-9210-3

Naoum C, Blanke P, Cavalcante JL, et al. Cardiac Computed Tomography and Magnetic Resonance Imaging in the Evaluation of Mitral and Tricuspid Valve Disease: Implications for Transcatheter Interventions. Circ Cardiovasc Imaging 2017; 10. doi: 10.1161/CIRCIMAGING.116.005331

Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol 2004; 43: 405-9. doi: 10.1016/j.jacc.2003.09.036

Hoke U, Auger D, Thijssen J, et al. Significant lead-induced tricuspid regurgitation is associated with poor prognosis at long-term follow-up. Heart 2014; 100: 960-8. doi: 10.1136/heartjnl-2013-304673

Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 63: e57-185. doi: 10.1016/j.jacc.2014.02.536

Rickard J, Wilkoff BL. Extraction of implantable cardiac electronic devices. Curr Cardiol Rep 2011; 13: 407-14. doi: 10.1007/s11886-011-0198-x

Wilkoff BL, Love CJ, Byrd CL, et al. Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA). Heart Rhythm 2009; 6: 1085-104. doi: 10.1016/j.hrthm.2009.05.020

Bongiorni MG, Burri H, Deharo JC, et al. 2018 EHRA expert consensus statement on lead extraction: recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries: endorsed by APHRS/HRS/LAHRS. Europace 2018; 20: 1217. doi: 10.1093/europace/euy050

Mehrotra D, Kejriwal NK. Tricuspid valve repair for torrential tricuspid regurgitation after permanent pacemaker lead extraction. Tex Heart Inst J 2011; 38: 305-7.

Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg 2012; 42: S1-44. doi: 10.1093/ejcts/ezs455

Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Rev Esp Cardiol (Engl Ed) 2022; 75: 524. doi: 10.1016/j.rec.2022.05.006

Nickenig G, Kowalski M, Hausleiter J, et al. Transcatheter Treatment of Severe Tricuspid Regurgitation With the Edge-to-Edge MitraClip Technique. Circulation 2017; 135: 1802-14. doi: 10.1161/CIRCULATIONAHA.116.024848

Perlman G, Praz F, Puri R, et al. Transcatheter Tricuspid Valve Repair With a New Transcatheter Coaptation System for the Treatment of Severe Tricuspid Regurgitation: 1-Year Clinical and Echocardiographic Results. JACC Cardiovasc Interv 2017; 10: 1994-2003. doi: 10.1016/j.jcin.2017.06.036

Mond HG, Proclemer A. The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009--a World Society of Arrhythmia's project. Pacing Clin Electrophysiol 2011; 34: 1013-27. doi: 10.1111/j.1540-8159.2011.03150.x

Addetia K, Harb SC, Hahn RT, et al. Cardiac Implantable Electronic Device Lead-Induced Tricuspid Regurgitation. JACC Cardiovasc Imaging 2019; 12: 622-36. doi: 10.1016/j.jcmg.2018.09.028

Magnusson P, Wennstrom L, Kastberg R, et al. Placement Of Cardiac PacemaKEr Trial (POCKET) - rationale and design: a randomized controlled trial. Heart Int 2017; 12: e8-e11. doi: 10.5301/heartint.5000235

Trankle CR, Gertz ZM, Koneru JN, et al. Severe tricuspid regurgitation due to interactions with right ventricular permanent pacemaker or defibrillator leads. Pacing Clin Electrophysiol 2018; 41: 845-53. doi: 10.1111/pace.13369

Al-Bawardy R, Krishnaswamy A, Rajeswaran J, et al. Tricuspid regurgitation and implantable devices. Pacing Clin Electrophysiol 2015; 38: 259-66. doi: 10.1111/pace.12530

Arabi P, Ozer N, Ates AH, et al. Effects of pacemaker and implantable cardioverter defibrillator electrodes on tricuspid regurgitation and right sided heart functions. Cardiol J 2015; 22: 637-44. doi: 10.5603/CJ.a2015.0060

Seo Y, Ishizu T, Nakajima H, et al. Clinical utility of 3-dimensional echocardiography in the evaluation of tricuspid regurgitation caused by pacemaker leads. Circ J 2008; 72: 1465-70. doi: 10.1253/circj.cj-08-0227

Delling FN, Hassan ZK, Piatkowski G, et al. Tricuspid Regurgitation and Mortality in Patients With Transvenous Permanent Pacemaker Leads. Am J Cardiol 2016; 117: 988-92. doi: 10.1016/j.amjcard.2015.12.038

Lee RC, Friedman SE, Kono AT, et al. Tricuspid Regurgitation Following Implantation of Endocardial Leads: Incidence and Predictors. Pacing Clin Electrophysiol 2015; 38: 1267-74. doi: 10.1111/pace.12701

Klutstein M, Balkin J, Butnaru A, et al. Tricuspid incompetence following permanent pacemaker implantation. Pacing Clin Electrophysiol 2009; 32 Suppl 1: S135-7. doi: 10.1111/j.1540-8159.2008.02269.x

de Cock CC, Vinkers M, Van Campe LC, et al. Long-term outcome of patients with multiple (> or = 3) noninfected transvenous leads: a clinical and echocardiographic study. Pacing Clin Electrophysiol 2000; 23: 423-6. doi: 10.1111/j.1540-8159.2000.tb00821.x

Mediratta A, Addetia K, Yamat M, Moss JD, Nayak HM, Burke MC, et al. 3D echocardiographic location of implantable device leads and mechanism of associated tricuspid regurgitation. JACC Cardiovasc Imaging 2014; 7: 337-47. doi: 10.1016/j.jcmg.2013.11.007

Cheng Y, Gao H, Tang L, et al. Clinical utility of three-dimensional echocardiography in the evaluation of tricuspid regurgitation induced by implantable device leads. Echocardiography 2016; 33: 1689-96. doi: 10.1111/echo.13314

Heaven DJ, Henein MY, Sutton R. Pacemaker lead related tricuspid stenosis: a report of two cases. Heart 2000; 83: 351-2. doi: 10.1136/heart.83.3.351

Wilner BR, Coffey JO, Mitrani R, et al. Perforated tricuspid valve leaflet resulting from defibrillator leads: a review of the literature. J Card Surg 2014; 29: 470-2. doi: 10.1111/jocs.12352

Lin G, Nishimura RA, Connolly HM, et al. Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads. J Am Coll Cardiol 2005; 45: 1672-5. doi: 10.1016/j.jacc.2005.02.037

Rajappan K. Permanent pacemaker implantation technique: part II. Heart 2009; 95: 334-42. doi: 10.1136/hrt.2008.156372

Barclay JL, Cross SJ, Leslie SJ. Entanglement of passive fix ventricular lead in tricuspid valve. Pacing Clin Electrophysiol 2008; 31: 138. doi: 10.1111/j.1540-8159.2007.00941.x

Moreno R, Zamorano J, Ortega A, et al. Tricuspid valve chordae rupture following pacemaker electrode replacement. Int J Cardiol 2003; 87: 291-2. doi: 10.1016/s0167-5273(02)00313-3

Andreas M, Gremmel F, Habertheuer A, et al. Case report: Pacemaker lead perforation of a papillary muscle inducing severe tricuspid regurgitation. J Cardiothorac Surg 2015; 10: 39. doi: 10.1186/s13019-015-0244-7

Fanari Z, Hammami S, Hammami MB, et al. The effects of right ventricular apical pacing with transvenous pacemaker and implantable cardioverter defibrillator on mitral and tricuspid regurgitation. J Electrocardiol 2015; 48: 791-7. doi: 10.1016/j.jelectrocard.2015.07.002

Chang JD, Manning WJ, Ebrille E, et al. Tricuspid Valve Dysfunction Following Pacemaker or Cardioverter-Defibrillator Implantation. J Am Coll Cardiol 2017; 69: 2331-41. doi: 10.1016/j.jacc.2017.02.055

Vaturi M, Kusniec J, Shapira Y, et al. Right ventricular pacing increases tricuspid regurgitation grade regardless of the mechanical interference to the valve by the electrode. Eur J Echocardiogr 2010; 11: 550-3. doi: 10.1093/ejechocard/jeq018

Stokes K, Anderson J, McVenes R, et al. The encapsulation of polyurethane-insulated transvenous cardiac pacemaker leads. Cardiovasc Pathol 1995; 4: 163-71. doi: 10.1016/1054-8807(95)00023-x

Candinas R, Duru F, Schneider J, et al. Postmortem analysis of encapsulation around long-term ventricular endocardial pacing leads. Mayo Clin Proc 1999; 74: 120-5. doi: 10.4065/74.2.120

Rainer PP, Schmidt A, Anelli-Monti M, et al. A swinging pacemaker lead promoting endocarditis and severe tricuspid regurgitation. J Am Coll Cardiol 2012; 59: e45. doi: 10.1016/j.jacc.2011.10.908

Enia F, Lo Mauro R, Meschisi F, et al. Right-sided infective endocarditis with acquired tricuspid valve stenosis associated with transvenous pacemaker: a case report. Pacing Clin Electrophysiol 1991; 14: 1093-7. doi: 10.1111/j.1540-8159.1991.tb02839.x

Nisanci Y, Yilmaz E, Oncul A, et al. Predominant tricuspid stenosis secondary to bacterial endocarditis in a patient with permanent pacemaker and balloon dilatation of the stenosis. Pacing Clin Electrophysiol 1999; 22: 393-6. doi: 10.1111/j.1540-8159.1999.tb00460.x

Lancellotti P, Moura L, Pierard LA, et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr 2010; 11: 307-32. doi: 10.1093/ejechocard/jeq031

Tamai R, Hara T, Yamada H, et al. Massive tricuspid regurgitation due to pacemaker-lead puncture of the tricuspid valve: successful diagnosis by 3-dimensional echocardiography. J Med Ultrason (2001) 2014; 41: 69-71. doi: 10.1007/s10396-013-0459-y

Nucifora G, Badano LP, Allocca G, et al. Severe tricuspid regurgitation due to entrapment of the anterior leaflet of the valve by a permanent pacemaker lead: role of real time three-dimensional echocardiography. Echocardiography 2007; 24: 649-52. doi: 10.1111/j.1540-8175.2007.00443.x

Miglioranza MH, Becker D, Jimenez-Nacher JJ, Moya JL, et al. A new view of an unusual pacemaker complication: role of three-dimensional transthoracic echocardiography. Echocardiography 2013; 30: E164-6. doi: 10.1111/echo.12188

Anwar AM, Geleijnse ML, Soliman OI, et al. Assessment of normal tricuspid valve anatomy in adults by real-time three-dimensional echocardiography. Int J Cardiovasc Imaging 2007; 23: 717-24. doi: 10.1007/s10554-007-9210-3

Naoum C, Blanke P, Cavalcante JL, et al. Cardiac Computed Tomography and Magnetic Resonance Imaging in the Evaluation of Mitral and Tricuspid Valve Disease: Implications for Transcatheter Interventions. Circ Cardiovasc Imaging 2017; 10. doi: 10.1161/CIRCIMAGING.116.005331

Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol 2004; 43: 405-9. doi: 10.1016/j.jacc.2003.09.036

Hoke U, Auger D, Thijssen J, et al. Significant lead-induced tricuspid regurgitation is associated with poor prognosis at long-term follow-up. Heart 2014; 100: 960-8. doi: 10.1136/heartjnl-2013-304673

Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 63: e57-185. doi: 10.1016/j.jacc.2014.02.536

Rickard J, Wilkoff BL. Extraction of implantable cardiac electronic devices. Curr Cardiol Rep 2011; 13: 407-14. doi: 10.1007/s11886-011-0198-x

Wilkoff BL, Love CJ, Byrd CL, et al. Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA). Heart Rhythm 2009; 6: 1085-104. doi: 10.1016/j.hrthm.2009.05.020

Bongiorni MG, Burri H, Deharo JC, et al. 2018 EHRA expert consensus statement on lead extraction: recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries: endorsed by APHRS/HRS/LAHRS. Europace 2018; 20: 1217. doi: 10.1093/europace/euy050

Mehrotra D, Kejriwal NK. Tricuspid valve repair for torrential tricuspid regurgitation after permanent pacemaker lead extraction. Tex Heart Inst J 2011; 38: 305-7.

Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg 2012; 42: S1-44. doi: 10.1093/ejcts/ezs455

Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Rev Esp Cardiol (Engl Ed) 2022; 75: 524. doi: 10.1016/j.rec.2022.05.006

Nickenig G, Kowalski M, Hausleiter J, et al. Transcatheter Treatment of Severe Tricuspid Regurgitation With the Edge-to-Edge MitraClip Technique. Circulation 2017; 135: 1802-14. doi: 10.1161/CIRCULATIONAHA.116.024848

Perlman G, Praz F, Puri R, et al. Transcatheter Tricuspid Valve Repair With a New Transcatheter Coaptation System for the Treatment of Severe Tricuspid Regurgitation: 1-Year Clinical and Echocardiographic Results. JACC Cardiovasc Interv 2017; 10: 1994-2003. doi: 10.1016/j.jcin.2017.06.036